Agilon Health, Inc. (NYSE:AGL - Get Free Report) shares fell 7.6% on Thursday . The stock traded as low as $2.13 and last traded at $2.12. 1,151,862 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 5,070,847 shares. The stock had previously closed at $2.29.
Analysts Set New Price Targets
Several brokerages recently weighed in on AGL. TD Cowen boosted their price target on shares of Agilon Health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. Citigroup raised Agilon Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Barclays boosted their target price on Agilon Health from $2.00 to $3.00 and gave the company an "underweight" rating in a research report on Thursday, May 8th. Evercore ISI cut their price objective on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a research report on Wednesday, July 9th. Finally, Cowen reiterated a "hold" rating on shares of Agilon Health in a report on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Agilon Health presently has an average rating of "Hold" and a consensus target price of $4.71.
Get Our Latest Analysis on AGL
Agilon Health Price Performance
The business's 50-day simple moving average is $2.23 and its two-hundred day simple moving average is $3.25.
Agilon Health (NYSE:AGL - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. The business had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The business's revenue was down 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.02) earnings per share. Sell-side analysts expect that Agilon Health, Inc. will post -0.59 EPS for the current year.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the business. Humankind Investments LLC acquired a new stake in shares of Agilon Health during the fourth quarter valued at about $30,000. Raymond James Financial Inc. acquired a new stake in shares of Agilon Health in the fourth quarter valued at approximately $33,000. Cerity Partners LLC acquired a new stake in Agilon Health during the 4th quarter worth $34,000. 111 Capital acquired a new position in Agilon Health during the second quarter worth $36,000. Finally, Nisa Investment Advisors LLC raised its stake in shares of Agilon Health by 244.9% during the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after buying an additional 6,783 shares during the last quarter.
About Agilon Health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.